Search research articles
Contact Us
Filters
Showing results (1-10 of 373) with videos related to
Page
of 38
Sort By:
The Journal of Pediatrics
|
May 21, 2004
Timing of initial cereal exposure in infancy and risk of islet autoimmunity
Mark A Atkinson
Diabetologia
|
January 21, 2014
Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box
Mark A Atkinson
Science Translational Medicine
|
August 19, 2011
Evaluating preclinical efficacy
Mark A Atkinson
Cold Spring Harbor Perspectives in Medicine
|
November 6, 2012
The pathogenesis and natural history of type 1 diabetes
Mark A Atkinson
Diabetes
|
October 25, 2014
Losing a grip on the notion of β-cell specificity for immune responses in type 1 diabetes: can we handle the truth?
Mark A Atkinson
Expert Review of Endocrinology & Metabolism
|
February 10, 2019
Trying to make a difference for those with Type 1 diabetes: a lesson in patience as well as a willingness to fail mightily
Mark A Atkinson
Diabetes
|
January 29, 2011
It's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes
Mark A Atkinson
Diabetes
|
April 28, 2005
ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease?
Mark A Atkinson
Pediatric Diabetes
|
August 14, 2015
The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept?
Xia Li, Mark A Atkinson
Diabetes
|
March 26, 2015
The streetlight effect in type 1 diabetes
Manuela Battaglia, Mark A Atkinson
Page
of 38
Search research articles
Search
Showing results (1-10 of 373) with videos related to
Sort By:
Page
of 38
The Journal of Pediatrics
|
May 21, 2004
Timing of initial cereal exposure in infancy and risk of islet autoimmunity
Mark A Atkinson
Diabetologia
|
January 21, 2014
Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box
Mark A Atkinson
Science Translational Medicine
|
August 19, 2011
Evaluating preclinical efficacy
Mark A Atkinson
Cold Spring Harbor Perspectives in Medicine
|
November 6, 2012
The pathogenesis and natural history of type 1 diabetes
Mark A Atkinson
Diabetes
|
October 25, 2014
Losing a grip on the notion of β-cell specificity for immune responses in type 1 diabetes: can we handle the truth?
Mark A Atkinson
Expert Review of Endocrinology & Metabolism
|
February 10, 2019
Trying to make a difference for those with Type 1 diabetes: a lesson in patience as well as a willingness to fail mightily
Mark A Atkinson
Diabetes
|
January 29, 2011
It's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes
Mark A Atkinson
Diabetes
|
April 28, 2005
ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease?
Mark A Atkinson
Pediatric Diabetes
|
August 14, 2015
The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept?
Xia Li, Mark A Atkinson
Diabetes
|
March 26, 2015
The streetlight effect in type 1 diabetes
Manuela Battaglia, Mark A Atkinson
Page
of 38